News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,362 Results
Type
Article (5095)
Company Profile (24)
Press Release (227243)
Multimedia
Podcasts (2)
Webinars (4)
Section
Business (82409)
Career Advice (464)
Deals (15064)
Drug Delivery (8)
Drug Development (19076)
Employer Resources (30)
FDA (3683)
Job Trends (3913)
News (120346)
Policy (7518)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (293)
Accelerated approval (6)
Adcomms (4)
Allergies (14)
Alliances (14819)
ALS (38)
Alzheimer's disease (295)
Antibody-drug conjugate (ADC) (41)
Approvals (3783)
Artificial intelligence (82)
Autoimmune disease (27)
Automation (5)
Bankruptcy (97)
Best Places to Work (2867)
Biosimilars (32)
Biotechnology (23)
Bladder cancer (34)
Brain cancer (7)
Breast cancer (102)
Cancer (891)
Cardiovascular disease (61)
Career advice (396)
Career pathing (3)
CAR-T (64)
CDC (2)
Cell therapy (166)
Cervical cancer (5)
Clinical research (16686)
Collaboration (356)
Compensation (374)
Complete response letters (8)
COVID-19 (311)
CRISPR (13)
C-suite (340)
Cystic fibrosis (28)
Data (1329)
Denatured (1)
Depression (21)
Diabetes (79)
Diagnostics (2129)
Digital health (8)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (32)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (37)
Earnings (42866)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39190)
Executive appointments (426)
FDA (4423)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (342)
Gene editing (24)
Generative AI (6)
Gene therapy (104)
GLP-1 (144)
Government (424)
Guidances (197)
Healthcare (5080)
HIV (10)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (39)
Immuno-oncology (7)
Indications (16)
Infectious disease (337)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (32)
Interviews (53)
IPO (7886)
IRA (3)
Job creations (1124)
Job search strategy (362)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (106)
Leadership (5)
Legal (2339)
Liver cancer (21)
Longevity (2)
Lung cancer (96)
Lymphoma (70)
Machine learning (3)
Management (10)
Manufacturing (142)
MASH (50)
Medical device (3918)
Medtech (3928)
Mergers & acquisitions (7586)
Metabolic disorders (217)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (540)
NextGen: Class of 2026 (1684)
Non-profit (731)
Now hiring (5)
Obesity (86)
Opinion (32)
Ovarian cancer (26)
Pain (26)
Pancreatic cancer (38)
Parkinson's disease (50)
Partnered (6)
Patents (53)
Patient recruitment (98)
Peanut (6)
People (25246)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (4994)
Phase 2 (7227)
Phase 3 (5790)
Pipeline (1981)
Policy (17)
Postmarket research (625)
Preclinical (1946)
Press Release (66)
Prostate cancer (57)
Psychedelics (3)
Radiopharmaceuticals (109)
Rare diseases (180)
Real estate (1887)
Recruiting (8)
Regulatory (5544)
Reports (17)
Research institute (308)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (49)
Series A (53)
Series B (56)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (5)
Startups (1019)
Stomach cancer (1)
Supply chain (13)
Tariffs (7)
The Weekly (1)
Vaccines (80)
Venture capital (9)
Weight loss (30)
Women's health (6)
Date
Today (37)
Last 7 days (169)
Last 30 days (565)
Last 365 days (8925)
2026 (836)
2025 (9038)
2024 (11038)
2023 (13210)
2022 (18679)
2021 (19703)
2020 (18263)
2019 (13223)
2018 (10218)
2017 (10011)
2016 (9176)
2015 (12147)
2014 (9601)
2013 (7723)
2012 (8342)
2011 (8809)
2010 (8648)
Location
Africa (187)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (1)
Asia (11787)
Australia (1692)
California (3547)
Canada (1140)
China (168)
Colorado (145)
Connecticut (164)
Delaware (70)
Europe (25501)
Florida (542)
Georgia (67)
Idaho (24)
Illinois (162)
India (16)
Indiana (106)
Iowa (9)
Japan (165)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (68)
Maryland (352)
Massachusetts (2816)
Michigan (104)
Minnesota (202)
Mississippi (1)
Missouri (32)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (16)
New Jersey (1025)
New Mexico (5)
New York (817)
North Carolina (480)
North Dakota (4)
Northern California (1859)
Ohio (116)
Oklahoma (5)
Oregon (6)
Pennsylvania (598)
Puerto Rico (2)
Rhode Island (19)
South America (280)
South Carolina (17)
Southern California (1305)
Tennessee (61)
Texas (485)
United States (12389)
Utah (111)
Virginia (85)
Washington D.C. (17)
Washington State (297)
West Virginia (2)
Wisconsin (58)
Wyoming (1)
232,362 Results for "idex corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IDEX Reports First Quarter Results
May 1, 2025
·
19 min read
Press Releases
Quantum-Si and IDEX Health & Science to Partner on Optics Module for Proteus™ Instrument
January 29, 2025
·
5 min read
Deals
IDEX Corporation Completes Acquisition of Iridian Spectral Technologies
IDEX Corporation announced that it has completed its previously-announced acquisition of Iridian Spectral Technologies, a global leader in designing and manufacturing thin-film, multi-layer optical filters.
May 22, 2023
·
5 min read
Deals
IDEX Corporation Completes Acquisition of Muon Group
IDEX Corporation (NYSE:IEX) today announced that it has completed its previously-announced acquisition of micro-precision technology manufacturing company Muon B.V. and its subsidiaries (“Muon Group”).
November 18, 2022
·
5 min read
Business
IDEX Corporation to Webcast Third Quarter 2022 Earnings Call
IDEX CORPORATION (NYSE:IEX) announced today that it has scheduled the broadcast of the company’s third quarter earnings conference call over the Internet on Wednesday, October 26, 2022 at 9:30 a.m. CT.
September 26, 2022
·
2 min read
Business
IDEX Corporation to Webcast Second Quarter 2022 Earnings Call
IDEX CORPORATION announced that it has scheduled the broadcast of the company’s second quarter earnings conference call over the Internet on Wednesday, July 27, 2022 at 9:30 a.m. CT.
June 30, 2022
·
2 min read
Business
IDEX Corporation Declare Regular Quarterly Cash Dividend - June 15, 2022
IDEX CORPORATION announced that its Board of Directors has approved a regular quarterly cash dividend of $0.60 per common share.
June 15, 2022
·
1 min read
Business
IDEX Reports Record Third Quarter 2022 Results and Raises Full Year Guidance
IDEX Corporation announced its financial results for the three month period ended September 30, 2022.
October 25, 2022
·
16 min read
Deals
IDEX Corporation’s Capital Deployment Continues with Agreement to Acquire Muon Group, a Leader in Precision Tech Manufacturing, for €700 million
IDEX Corporation announced that it has entered into a definitive agreement to acquire micro-precision technology manufacturing company Muon B.V. and its subsidiaries for cash consideration of €700 million.
September 13, 2022
·
8 min read
Business
IDEX Reports Strong Second Quarter Results
IDEX Corporation (NYSE: IEX) today announced its financial results for the three month period ended June 30, 2022.
July 26, 2022
·
33 min read
1 of 23,237
Next
